Spark Investment Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Spark Investment Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,800	Closed	-$227K	–	746
2018 Q4	$227K	Buy	+7,800	New	+$346K	0.02%	487
2015 Q4	–	Sell	-7,620	Closed	-$1.11M	–	880
2015 Q3	$1.11M	Sell	7,620 -3,430	-31%	-$630K	0.14%	235
2015 Q2	$2.35M	Buy	+11,050	New	+$2.71M	0.33%	90

Other funds holding BLCM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Spark Investment Management's BLCM Position: Q1 2019 in Review

Spark Investment Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2019, closing a stake of 7,800 shares — an estimated $227K sold.

Spark Investment Management first reported a position in BLCM in Q2 2015 and held it in 3 quarters. The position peaked at $2.35M in Q2 2015. 94 funds tracked by Wall St. Rank hold BLCM as of Q1 2019.

Spark Investment Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Spark Investment Management sold 7,800 Bellicum Pharmaceuticals, Inc. shares in Q1 2019, an estimated $227K.
Spark Investment Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
Spark Investment Management's Bellicum Pharmaceuticals, Inc. position peaked at $2.35M in Q2 2015.
94 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.